SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Oturai, A. B.
Right arrow Articles by Sorensen, P. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oturai, A. B.
Right arrow Articles by Sorensen, P. S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs

Annette Bang Oturai

Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, annette{at}oturai.net

Lars P Ryder

Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Sten Fredrikson

Department of Neurology, Huddinge University Hospital, Karolinska Institute, Huddinge, Sweden

Kjell-Morten Myhr

The Multiple Sclerosis National Competence Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway

Elisabeth G Celius

Department of Neurology, UllevaSl University Hospital, Oslo, Norway

Hanne Flinstad Harbo

Institute of Immunology, The National Hospital, Oslo, Norway

Oluf Andersen

Department of Neurology, Göteborg University Hospital, Göteborg, Sweden

Eva ASkesson

Department of Neurology, Huddinge University Hospital, Karolinska Institute, Huddinge, Sweden

Jan Hillert

Department of Neurology, Huddinge University Hospital, Karolinska Institute, Huddinge, Sweden

Hans O Madsen

Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Harald Nyland

The Multiple Sclerosis National Competence Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway

Anne Spurkland

Institute of Immunology, The National Hospital, Oslo, Norway

Pameli Datta

Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Arne Svejgaard

Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Per S Sorensen

Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Background: Investigation of coaffected sib pairs is one method to determine the genetic influence on the clinical presentatio n of many complex diseases, such as multiple sclerosis (MS). Investigation of the clinical concordance in coaffected sib pairs may be a prerequisite to identify genes that modify the clinical outcome. The aim of this study was to investigate a possible genetic influence on selected demographic and clinical variables among familial Scandinavian MS cases. Material and methods: We identified 136 C aucasian Scandinavian families with MS coaffected sib pairs from Denmark, Norway, and Sweden. C ohen’s kappa coefficient and the intraclass correlation coefficient were used to assess concordances in sib pairs. Furthermore, clinical features and HLA-DR2 carrier status were compared among the probands of sib pairs. Results: We found significant concordance of the disease course (k=0.28, PB-0.001) and adjusted age of onset (r =0.23, P=0.028). Among probands of sib pairs, HLA-DR2 carrier patients had a younger age of onset (P=0.024). Conclusion: A nalyses of Scandinavian coaffected sib pairs suggest that disease course and age of onset are partly under genetic control. Furthermore, HLA-DR2 in probands of sib pairs suggests importance for age of onset.

Key Words: clinical features • HLA • multiple sclerosis • sib pairs

Multiple Sclerosis, Vol. 10, No. 1, 5-8 (2004)
DOI: 10.1191/1352458504ms975oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
T Hansen, A Skytthe, E Stenager, H C Petersen, H Bronnum-Hansen, and K O Kyvik
Concordance for multiple sclerosis in Danish twins: an update of a nationwide study
Multiple Sclerosis, October 1, 2005; 11(5): 504 - 510.
[Abstract] [PDF]



Advertisement